These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2780100)

  • 1. [Diffusion of ceftriaxone in healthy and infected peritoneal tissue].
    Rio Y; Bur F; Didion J; Jurin F
    Pathol Biol (Paris); 1989 May; 37(5):437-41. PubMed ID: 2780100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diffusion of ceftriaxone in the renal parenchyma].
    Freney J; Mongin-Long D; Meugnier H; Nervi C; Laville M; Zech P; Fleurette J
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):727-9. PubMed ID: 3309805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma and tissue concentration of ceftriaxone following a one-time i.v. dose of 2 g].
    Küttel JC; Petropoulos P; Crevoisier C
    Schweiz Med Wochenschr; 1988 May; 118(20):786-8. PubMed ID: 3387979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M; Benevent D; Denis F
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ceftriaxone after intravenous administration to CAPD-patients with and without peritonitis.
    Favre H; Probst P
    Chemioterapia; 1987 Jun; 6(2 Suppl):273-4. PubMed ID: 3509411
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diffusion of ceftriaxone in human bone tissue].
    Soudry B; Sirot J; Lopitaux R; Dumont C; Delisle JJ; Parenton M
    Pathol Biol (Paris); 1986 Sep; 34(7):859-62. PubMed ID: 3537931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of local and systemic antibiotics in rat fecal peritonitis.
    Perdue PW; Kazarian KK; Nevola J; Law WR; Williams T
    J Surg Res; 1994 Sep; 57(3):360-5. PubMed ID: 8072283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary and tonsillar distribution of ceftriaxone and cefonicid and the resultant bactericidal activity of the organ].
    Fraschini F; Scaglione F
    Recenti Prog Med; 1990 Jan; 81(1):41-6. PubMed ID: 2236826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
    Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of surgical biliary pathology on the diffusion of ceftriaxone in the biliary tract].
    Guyot L; Naline E; Moreau J; Gnassounou JP; Varoquaux O; Barbe G; Estenne B; Pays M; Advenier C
    Therapie; 1989; 44(4):285-9. PubMed ID: 2595647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diffusion of ceftriaxone into the human brain].
    Dorche G; Lucht F; Bertrand AM; Vinhas E; Gibaud H; Aubert G; Brunon J
    Pathol Biol (Paris); 1990 Jun; 38(6):638-42. PubMed ID: 2374699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide inhibition decreases neutrophil adhesion at the inflammatory site, while increasing adhesion in remote organs in peritonitis.
    Fukatsu K; Saito H; Han I; Furukawa S; Hashiguchi Y; Lin MT; Matsuda T; Inaba T; Inoue T; Ikeda S; Yasuhara H; Muto T
    J Surg Res; 1997 Feb; 68(1):79-86. PubMed ID: 9126199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
    Tuncer I; Topcu N; Durmus A; Turkdogan MK
    Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal ceftriaxone].
    Ragnaud JM; Bezian MC; Dupon M; Marceau C; Wone C
    Pathol Biol (Paris); 1988 May; 36(5):552-6. PubMed ID: 3043356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intravitreal penetration of ceftriaxone in man following systemic administration.
    Sharir M; Triester G; Kneer J; Rubinstein E
    Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2179-83. PubMed ID: 2793358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and Peritoneal Ceftriaxone Concentrations After Intraperitoneal Administration in Horses With Septic Peritonitis.
    Alonso JM; Martins ES; Peccinini RG; Rosa GS; Guerra ST; Ribeiro MG; Santos B; García HDM; Watanabe MJ; Takahira RK; Rodrigues CA; Alves ALG; Hussni CA
    J Equine Vet Sci; 2021 Jan; 96():103310. PubMed ID: 33349404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of ceftriaxone (R013-9904) in the treatment of septicemia caused by gram-negative bacilli].
    Naessens A; Pierard D; Roels P; Lauwers S
    Pathol Biol (Paris); 1983 May; 31(5):362-5. PubMed ID: 6312398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of cephazolin, ceftazidime, and ceftriaxone distribution in nucleus pulposus.
    Yan D; Li J; Zhang Z; Zhu H
    Arch Orthop Trauma Surg; 2012 Jul; 132(7):969-73. PubMed ID: 22526195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of ceftriaxone in hemodialysis].
    Laville M; Mercatello A; Freney J; Pozet N; Meugnier H; Labeeuw M; Fleurette J; Zech P
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):719-23. PubMed ID: 3309803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ceftriaxone, a cephalosporin with high hepatic elimination. Evaluation of its biliary clearance in man. Therapeutic value].
    Brogard JM; Jehl F; Paris-Bockel D; Sini F; Blickle JF; Adloff M; Monteil H
    Schweiz Med Wochenschr; 1987 Oct; 117(40):1549-59. PubMed ID: 3672089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.